Key facts
- This page summarizes Chad Gassert's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Feb 2025, 20:14.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
Footnote F2
These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
Footnote F3
The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.